OrthoPediatrics Corp. (NASDAQ:KIDS) Receives $24.67 Average Price Target from Brokerages

OrthoPediatrics Corp. (NASDAQ:KIDS) has received an average rating of “Moderate Buy” from the eleven research firms that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $24.6667.

A number of research firms recently weighed in on KIDS. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of OrthoPediatrics in a report on Thursday, January 22nd. Wall Street Zen raised shares of OrthoPediatrics from a “sell” rating to a “hold” rating in a report on Saturday. Truist Financial boosted their price target on shares of OrthoPediatrics from $19.00 to $20.00 and gave the company a “hold” rating in a research report on Monday, March 2nd. Canaccord Genuity Group assumed coverage on OrthoPediatrics in a research report on Wednesday, December 10th. They issued a “buy” rating and a $24.00 price objective on the stock. Finally, TD Cowen raised OrthoPediatrics to a “strong-buy” rating in a research note on Tuesday, January 27th.

Institutional Trading of OrthoPediatrics

A number of large investors have recently modified their holdings of KIDS. Russell Investments Group Ltd. grew its holdings in shares of OrthoPediatrics by 433.1% during the third quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after purchasing an additional 1,139 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in OrthoPediatrics by 5,226.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock valued at $46,000 after purchasing an additional 2,561 shares during the last quarter. Caption Management LLC purchased a new position in OrthoPediatrics in the 3rd quarter worth approximately $54,000. BNP Paribas Financial Markets increased its holdings in shares of OrthoPediatrics by 60.2% in the 3rd quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after buying an additional 1,235 shares during the last quarter. Finally, State of Wyoming increased its holdings in shares of OrthoPediatrics by 189.7% in the 4th quarter. State of Wyoming now owns 6,822 shares of the company’s stock worth $121,000 after buying an additional 4,467 shares during the last quarter. Institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Price Performance

Shares of NASDAQ KIDS opened at $18.05 on Wednesday. The company has a debt-to-equity ratio of 0.28, a quick ratio of 3.52 and a current ratio of 5.55. OrthoPediatrics has a fifty-two week low of $15.28 and a fifty-two week high of $26.40. The stock has a market cap of $456.30 million, a PE ratio of -10.68 and a beta of 1.07. The stock has a fifty day moving average of $17.75 and a 200-day moving average of $18.12.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings data on Thursday, February 26th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.11. The business had revenue of $61.61 million for the quarter, compared to analysts’ expectations of $61.27 million. OrthoPediatrics had a negative return on equity of 6.70% and a negative net margin of 16.77%. Equities research analysts anticipate that OrthoPediatrics will post -0.93 earnings per share for the current year.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.